R. Cook

发表

A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.

P. Korthuis, K. Priest, X. Levander, 2021, The International journal on drug policy.

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study

Daniel M. Hartung, U. Ghitza, D. McCarty, 2022, Addiction Science & Clinical Practice.

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Kim A. Hoffman, D. McCarty, Elizabeth H. Payne, 2022, Addiction.

Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R2): a multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in research

Miriam R. Elman, P. Korthuis, J. Lapidus, 2022, BMJ Open.

Expanding Inpatient Addiction Consult Services Through Accountable Care Organizations for Medicaid Enrollees: A Modeling Study

D. McCarty, C. King, Cynthia D. Morris, 2022, Journal of addiction medicine.

Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis

Kim A. Hoffman, Javier Ponce Terashima, D. McCarty, 2022, Journal of Substance Abuse Treatment.

Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality.

Cynthia D. Morris, P. T. Korthuis, Honora Englander, 2021, The International journal on drug policy.

Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities

R. Westergaard, Randall T Brown, H. Cooper, 2022, JAMA network open.

Predictors of having naloxone in urban and rural Oregon findings from NHBS and the OR-HOPE study.

T. Menza, P. Korthuis, G. Leichtling, 2021, Drug and alcohol dependence.

HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial.

P. Korthuis, L. M. Giang, Thuan Nguyen, 2021, The lancet. HIV.

Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam.

P. Korthuis, E. N. Waddell, L. M. Giang, 2021, Journal of substance abuse treatment.

Contraception and Healthcare Utilization by Reproductive-Age Women Who Use Drugs in Rural Communities: a Cross-Sectional Survey

S. Magnusson, R. Westergaard, X. Levander, 2022, Journal of General Internal Medicine.

Chronic Alcohol Exposure Among People Living with HIV Is Associated with Innate Immune Activation and Alterations in Monocyte Phenotype and Plasma Cytokine Profile

P. Korthuis, R. Sékaly, S. Ribeiro, 2022, Frontiers in Immunology.

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

K. Humphreys, O. Arah, X. Levander, 2023, Addiction Science & Clinical Practice.

Substance use disorder treatment and technology access among people who use drugs in rural areas of the United States: A cross-sectional survey.

R. Westergaard, X. Levander, Dana Button, 2022, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease.

P. Korthuis, L. Fanucchi, G. Lucas, 2021, Drug and alcohol dependence.

Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam.

P. Korthuis, L. M. Giang, Dana Button, 2021, The International journal on drug policy.

Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone.

M. Pavlicova, E. Nunes, J. Rotrosen, 2022, Drug and alcohol dependence.

Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder

P. Korthuis, C. Morris, Honora Englander, 2021, Journal of addiction medicine.

A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study

M. Herink, A. Seaman, R. Cook, 2023, Addiction Science & Clinical Practice.

A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.

M. Trivedi, T. Carmody, S. Shoptaw, 2023, Addiction.